TERN Financials

Terns Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$6.12B

EPS

$-1.67

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-88.85M

EPS (Diluted)

$-1.12

Balance Sheet Highlights

Total Assets

$363.93M

Total Liabilities

$18.06M

Shareholders Equity

Cash & Equivalents

$161.44M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-70.02M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is TERN revenue?

View TERN's income statement for detailed revenue data.

Is TERN profitable?

TERN reported a loss of $88.85M in the most recent quarter.

What is TERN market cap?

TERN has a market capitalization of $6.12B, making it a mid-cap stock.

Does TERN have debt?

View TERN's balance sheet for debt information.

What is TERN cash flow?

Cash flow data is available in the full financial statements.